{
    "Trade/Device Name(s)": [
        "CONFIRM anti-Estrogen Receptor (SP1) Rabbit Monoclonal Primary Antibody",
        "CONFIRM anti-ER (SP1)"
    ],
    "Submitter Information": "Ventana Medical Systems, Inc.",
    "510(k) Number": "K110215",
    "Predicate Device Reference 510(k) Number(s)": [
        "K081286"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYA"
    ],
    "Summary Letter Date": "December 17, 2012",
    "Summary Letter Received Date": "November 26, 2012",
    "Submission Date": "November 23, 2012",
    "Regulation Number(s)": [
        "21 CFR 864.1860"
    ],
    "Regulation Name(s)": [
        "Immunohistochemistry reagents and kits"
    ],
    "Analyte Class(es)": [
        "anatomic pathology"
    ],
    "Analyte(s)": [
        "Estrogen Receptor (ER) alpha"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded breast tissue sections"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Ventana BenchMark XT",
        "Ventana BenchMark ULTRA"
    ],
    "Method(s)/Technology(ies)": [
        "Immunohistochemistry (IHC)"
    ],
    "Methodologies": [
        "Immunohistochemical staining"
    ],
    "Submission Type(s)": [
        "Antibody",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for CONFIRM anti-Estrogen Receptor (SP1) Rabbit Monoclonal Primary Antibody for qualitative IHC detection of ER alpha in breast tissue",
    "Indications for Use Summary": "For in vitro diagnostic use in the qualitative detection of estrogen receptor antigen in formalin-fixed, paraffin-embedded breast tissue on Ventana automated slide stainers to aid management, prognosis, and prediction of hormone therapy for breast carcinoma",
    "fda_folder": "Hematology"
}